259 related articles for article (PubMed ID: 33050756)
1. Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes.
Han D; Tao J; Fu R; Shao Z
Innate Immun; 2020 Nov; 26(8):703-715. PubMed ID: 33050756
[TBL] [Abstract][Full Text] [Related]
2. CD8
Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
[TBL] [Abstract][Full Text] [Related]
3. Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway.
Qi X; Jiang H; Liu P; Xie N; Fu R; Wang H; Liu C; Zhang T; Wang H; Shao Z
Leuk Lymphoma; 2021 Jan; 62(1):218-223. PubMed ID: 32985300
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
Lee CR; Lee W; Cho SK; Park SG
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
[TBL] [Abstract][Full Text] [Related]
5. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
6. TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8
Yu S; Ren X; Meng F; Guo X; Tao J; Zhang W; Liu Z; Fu R; Li L
Immunology; 2023 Feb; 168(2):273-289. PubMed ID: 35470423
[TBL] [Abstract][Full Text] [Related]
7. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494.
Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701
[TBL] [Abstract][Full Text] [Related]
9. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
10. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
11. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
[TBL] [Abstract][Full Text] [Related]
13. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells inhibit natural killer cells in myelodysplastic syndromes through the TIGIT/CD155 pathway.
Yue J; Li J; Ma J; Zhai Y; Shen L; Zhang W; Li L; Fu R
Hematology; 2023 Dec; 28(1):2166333. PubMed ID: 36651499
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
[TBL] [Abstract][Full Text] [Related]
16. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
17. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
Front Immunol; 2018; 9():1179. PubMed ID: 29896199
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-Derived Suppressor Cells in Lung Transplantation.
Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
Front Immunol; 2019; 10():900. PubMed ID: 31080450
[TBL] [Abstract][Full Text] [Related]
19. Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli.
Leiber A; Schwarz J; Köstlin N; Spring B; Fehrenbach B; Katava N; Poets CF; Gille C
Eur J Immunol; 2017 Jun; 47(6):1009-1021. PubMed ID: 28493377
[TBL] [Abstract][Full Text] [Related]
20. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
